Nanoform Finland Oyj

Helsinki Stock Exchange NANOFH.HE

Nanoform Finland Oyj Price to Sales Ratio (P/S) on January 14, 2025: 40.27

Nanoform Finland Oyj Price to Sales Ratio (P/S) is 40.27 on January 14, 2025, a -22.96% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Nanoform Finland Oyj 52-week high Price to Sales Ratio (P/S) is 86.29 on January 30, 2024, which is 114.30% above the current Price to Sales Ratio (P/S).
Nanoform Finland Oyj 52-week low Price to Sales Ratio (P/S) is 33.03 on November 06, 2024, which is -17.98% below the current Price to Sales Ratio (P/S).
Nanoform Finland Oyj average Price to Sales Ratio (P/S) for the last 52 weeks is 55.49.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Helsinki Stock Exchange: NANOFH.HE

Nanoform Finland Oyj

CEO	Prof. Edward Olof Haeggstrom
IPO Date	June 4, 2020
Location	Finland
Headquarters	Cultivator II
Employees	174
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Engineering Services

Description

Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.

Key trends

Past 5 years